Robust Mendelian Randomization Analysis by Automatically Selecting Valid Genetic Instruments with Applications to Identify Plasma Protein Biomarkers for Alzheimer’s Disease

preprint OA: closed
Full text JSON View at publisher
AI-generated deep summary by claude@2026-07, 2026-07-04 · read from full text

The paper develops a robust Mendelian randomization framework that automatically selects valid genetic instruments and then performs post-selection inference (MR-SPI) using two-sample genome-wide summary statistics. Using UK Biobank proteomics data from 54,306 participants, the authors analyze associations of 912 plasma proteins with Alzheimer’s disease risk and report 7 proteins (TREM2, PILRB, PILRA, EPHA1, CD33, RET, CD55) as significantly associated. They further use AlphaFold2 to predict how missense genetic variants could alter the 3D structures of these proteins, aiming to provide biological insight into disease etiology. The authors frame the work as a preprint that is under review and do not provide additional explicit limitations in the provided text. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Mendelian randomization (MR) uses genetic variants as instrumental variables (IVs) to infer the causal effect of a modifiable exposure on the outcome of interest by removing unmeasured confounding bias. However, some genetic variants might be invalid IVs due to violations of core IV assumptions. MR analysis with invalid IVs might lead to biased causal effect estimate and misleading scientific conclusions. To address this challenge, we propose a novel MR method that first Selects valid genetic IVs and then performs Post-selection Inference (MR-SPI) based on two-sample genome-wide summary statistics. We analyze 912 plasma proteins using the large-scale UK Biobank proteomics data in 54,306 participants and identify 7 proteins (TREM2, PILRB, PILRA, EPHA1, CD33, RET, CD55) significantly associated with the risk of Alzheimer's disease. We employ AlphaFold2 to predict the 3D structural alterations of these 7 proteins due to missense genetic variations, providing new insights into their biological functions in disease etiology.
Full text 11,991 characters · extracted from preprint-html · click to expand
Robust Mendelian Randomization Analysis by Automatically Selecting Valid Genetic Instruments with Applications to Identify Plasma Protein Biomarkers for Alzheimer’s Disease | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Robust Mendelian Randomization Analysis by Automatically Selecting Valid Genetic Instruments with Applications to Identify Plasma Protein Biomarkers for Alzheimer’s Disease Zhonghua Liu, Minhao Yao, Gary Miller, Badri Vardarajan, Andrea Baccarelli, and 1 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-3703437/v1 This work is licensed under a CC BY 4.0 License Status: Under Review Version 1 posted You are reading this latest preprint version Abstract Mendelian randomization (MR) uses genetic variants as instrumental variables (IVs) to infer the causal effect of a modifiable exposure on the outcome of interest by removing unmeasured confounding bias. However, some genetic variants might be invalid IVs due to violations of core IV assumptions. MR analysis with invalid IVs might lead to biased causal effect estimate and misleading scientific conclusions. To address this challenge, we propose a novel MR method that first Selects valid genetic IVs and then performs Post-selection Inference (MR-SPI) based on two-sample genome-wide summary statistics. We analyze 912 plasma proteins using the large-scale UK Biobank proteomics data in 54,306 participants and identify 7 proteins (TREM2, PILRB, PILRA, EPHA1, CD33, RET, CD55) significantly associated with the risk of Alzheimer's disease. We employ AlphaFold2 to predict the 3D structural alterations of these 7 proteins due to missense genetic variations, providing new insights into their biological functions in disease etiology. Biological sciences/Genetics/Genetic association study/Genome-wide association studies Health sciences/Medical research/Epidemiology Full Text Additional Declarations There is NO Competing Interest. Supplementary Files SPIsupplement.pdf Robust Mendelian Randomization Analysis by Automatically Selecting Valid Genetic Instruments with Applications to Identify Plasma Protein Biomarkers for Alzheimer’s Disease Cite Share Download PDF Status: Under Review Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-3703437","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":266114012,"identity":"fe60bbe4-1bd6-4443-92c2-6b7b526b5b49","order_by":0,"name":"Zhonghua Liu","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAABAElEQVRIie3QMUsDMRTA8RcexCU6R0q5r3DloBRa/Cw5CneLs2RwOAmkS8HV4mcQnDpfOdDlqJsU4nDSL3BuN4kBqXjDg44d8p9eQn7DC0AodIqd4Wur9OxwnABIVvgBaYI8g7bODkd5DBFjtrLVf/J7T4rIwHh/bt+i+L1qoNMyfXo0dy3oaVoQhBnIE7F1o2eXxWxZy3T9sTES6pwkiFAOxI1TsbsGZNaTXVpIZiuScGTFQPBtj5iOfdNEIPLLB1v2iPWfRhOJHOO2no9WfpeN3yXxu9iJeskTikSL+69G6avows0/m07Phmu32O/a2+mQIr3Kv0kd8zwUCoVCZD+uYlxdA5hKVAAAAABJRU5ErkJggg==","orcid":"https://orcid.org/0000-0003-3048-9823","institution":"Columbia University","correspondingAuthor":true,"prefix":"","firstName":"Zhonghua","middleName":"","lastName":"Liu","suffix":""},{"id":266114013,"identity":"d21becf1-d86b-4798-b3fc-1a285d47ea75","order_by":1,"name":"Minhao Yao","email":"","orcid":"","institution":"The University of Hong Kong","correspondingAuthor":false,"prefix":"","firstName":"Minhao","middleName":"","lastName":"Yao","suffix":""},{"id":266114014,"identity":"763c6e12-e2b0-400b-9e1d-53862cf0c355","order_by":2,"name":"Gary Miller","email":"","orcid":"","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Gary","middleName":"","lastName":"Miller","suffix":""},{"id":266114015,"identity":"93b93868-ada6-424c-bb3b-fb1ae9ac6123","order_by":3,"name":"Badri Vardarajan","email":"","orcid":"https://orcid.org/0000-0002-5560-4085","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Badri","middleName":"","lastName":"Vardarajan","suffix":""},{"id":266114016,"identity":"d0a50539-6e80-4bf5-b8f1-168dee803760","order_by":4,"name":"Andrea Baccarelli","email":"","orcid":"","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Andrea","middleName":"","lastName":"Baccarelli","suffix":""},{"id":266114017,"identity":"eaa4c08d-b445-4d5c-8a5e-2b6a8b520866","order_by":5,"name":"Zijian Guo","email":"","orcid":"","institution":"Rutgers University","correspondingAuthor":false,"prefix":"","firstName":"Zijian","middleName":"","lastName":"Guo","suffix":""}],"badges":[],"createdAt":"2023-12-04 02:55:55","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-3703437/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-3703437/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":50010973,"identity":"c13fb291-72a2-425b-971c-d45f76a23ae8","added_by":"auto","created_at":"2024-01-23 05:04:32","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1443335,"visible":true,"origin":"","legend":"","description":"","filename":"MRSPIsubmission.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3703437/v1_covered_94b1d62c-7738-43b7-bc79-759ef330885d.pdf"},{"id":50010714,"identity":"68021dd6-75c1-4ab4-a4fb-cdda9b13a725","added_by":"auto","created_at":"2024-01-23 04:56:23","extension":"pdf","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":7200261,"visible":true,"origin":"","legend":"Robust Mendelian Randomization Analysis by Automatically Selecting Valid Genetic Instruments with Applications to Identify Plasma Protein Biomarkers for Alzheimer\u0026#x2019;s Disease","description":"","filename":"SPIsupplement.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3703437/v1/aa4abc2d024a041c86af8db6.pdf"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e Competing Interest.","formattedTitle":"Robust Mendelian Randomization Analysis by Automatically Selecting\r\nValid Genetic Instruments with Applications to Identify Plasma Protein Biomarkers for Alzheimer’s Disease","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"nature-portfolio","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"","title":"Nature Portfolio","twitterHandle":"","acdcEnabled":false,"dfaEnabled":false,"editorialSystem":"ejp","reportingPortfolio":"","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-3703437/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-3703437/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"Mendelian randomization (MR) uses genetic variants as instrumental variables (IVs) to infer the causal effect of a modifiable exposure on the outcome of interest by removing unmeasured confounding bias. However, some genetic variants might be invalid IVs due to violations of core IV assumptions. MR analysis with invalid IVs might lead to biased causal effect estimate and misleading scientific conclusions. To address this challenge, we propose a novel MR method that first Selects valid genetic IVs and then performs Post-selection Inference (MR-SPI) based on two-sample genome-wide summary statistics. We analyze 912 plasma proteins using the large-scale UK Biobank proteomics data in 54,306 participants and identify 7 proteins (TREM2, PILRB, PILRA,\r\nEPHA1, CD33, RET, CD55) significantly associated with the risk of Alzheimer's disease. We employ AlphaFold2 to predict the 3D structural alterations of these 7 proteins due to missense genetic variations, providing new insights into their biological\r\nfunctions in disease etiology.","manuscriptTitle":"Robust Mendelian Randomization Analysis by Automatically Selecting\nValid Genetic Instruments with Applications to Identify Plasma Protein Biomarkers for Alzheimer’s Disease","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-01-23 04:56:18","doi":"10.21203/rs.3.rs-3703437/v1","editorialEvents":[],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"nature-communications","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"NCOMMS","sideBox":"Learn more about [Nature Communications](http://www.nature.com/ncomms/)","snPcode":"","submissionUrl":"https://mts-ncomms.nature.com/","title":"Nature Communications","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"ejp","reportingPortfolio":"Nature Communications","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"e8938298-30d9-4d8e-b86b-260ec8699919","owner":[],"postedDate":"January 23rd, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"under-review","subjectAreas":[{"id":28038173,"name":"Biological sciences/Genetics/Genetic association study/Genome-wide association studies"},{"id":28038174,"name":"Health sciences/Medical research/Epidemiology"}],"tags":[],"updatedAt":"2024-01-23T04:56:18+00:00","versionOfRecord":[],"versionCreatedAt":"2024-01-23 04:56:18","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-3703437","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-3703437","identity":"rs-3703437","version":["v1"]},"buildId":"qtupq5eGEP_6zYnWcrvyt","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00